Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Multi Bintang Indonesia Tbk. (MLBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Multi Bintang Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Multi Bintang Indonesia Tbk. trades at Rp6,975 (market cap 14.85T, 42.2K 24h volume). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 47× Diagnos Laboratorium Utama Tbk.'s market cap, and Multi Bintang Indonesia Tbk. is more actively traded (42.2K versus 41.7K). Which is the better fit depends on your goals.
| DGNS | MLBI | |
|---|---|---|
Market Cap | 316.25B | 14.85T |
Volume | 41.7K | 42.2K |
Lot | 417 | 422 |
Turnover | 9.66M | 293.55M |
Average Price | 231.65 | 6,956.22 |
Value | 9.66M | 293.55M |
Indicative Equilibrium Price | 230 | 6,975 |
Indicative Equilibrium Volume | 2.4K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Multi Bintang Indonesia Tbk.
PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).
Read more on MLBI →
